Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors

BACKGROUND: Recombinant human soluble thrombomodulin (rTM) has been established and introduced in the clinic as a standard treatment for disseminated intravascular coagulation (DIC). However, the efficacy and safety of rTM for DIC associated with solid tumors (DIC-STs) have not been fully establishe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouchi, Kota, Takahashi, Shin, Chikamatsu, Sonoko, Ito, Shukuei, Takahashi, Yoshikazu, Kawai, Sadayuki, Okita, Akira, Kasahara, Yuki, Okada, Yoshinari, Imai, Hiroo, Komine, Keigo, Saijo, Ken, Takahashi, Masahiro, Shirota, Hidekazu, Takahashi, Masanobu, Gamoh, Makio, Ishioka, Chikashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097084/
https://www.ncbi.nlm.nih.gov/pubmed/29511940
http://dx.doi.org/10.1007/s10147-018-1261-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097084/
https://www.ncbi.nlm.nih.gov/pubmed/29511940
http://dx.doi.org/10.1007/s10147-018-1261-z

Ejemplares similares